CLINICAL TRIALS PROFILE FOR SAMSCA
✉ Email this page to a colleague
All Clinical Trials for SAMSCA
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01199198 ↗ | Tolvaptan in Hyponatremic Cancer Patients | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 4 | 2011-05-01 | The goal of this clinical research study is to learn if tolvaptan can help raise salt (sodium) levels in the cancer patients' blood by removing extra body water as urine. |
| NCT01199198 ↗ | Tolvaptan in Hyponatremic Cancer Patients | Completed | M.D. Anderson Cancer Center | Phase 4 | 2011-05-01 | The goal of this clinical research study is to learn if tolvaptan can help raise salt (sodium) levels in the cancer patients' blood by removing extra body water as urine. |
| NCT01227512 ↗ | Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia | Terminated | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 3 | 2010-10-01 | The purpose of this study is to determine if hospitalized patients with symptomatic hyponatremia treated with tolvaptan are in the hospital for less time than patients treated with fluid restriction. The study will also test if tolvaptan is better than fluid restriction in treating the symptoms of hyponatremia in hospitalized patients. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SAMSCA
Condition Name
Clinical Trial Locations for SAMSCA
Trials by Country
Clinical Trial Progress for SAMSCA
Clinical Trial Phase
Clinical Trial Sponsors for SAMSCA
Sponsor Name
